A multicentre randomized/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: influence of a 1 week shortening overall time

This publication has 9 references indexed in Scilit:

• A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
  Published by Elsevier ,2000
• Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer – report on 3-year tumour control and normal tissue toxicity
  Radiotherapy and Oncology, 2000
• Quality assurance of the EORTC radiotherapy trial 22931 for head and neck carcinomas: the dummy run
  Radiotherapy and Oncology, 1998
• Hyperfractionated radiotherapy in head and neck cancer: a second look at the clinical data
  Radiotherapy and Oncology, 1998
• Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy
  Radiotherapy and Oncology, 1998
• Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial
  Radiotherapy and Oncology, 1997
• A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
  Radiotherapy and Oncology, 1997
• A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer
  Published by Elsevier ,1997
• 110Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week — Preliminary report from the Dahanca 6 and 7 trial
  Radiotherapy and Oncology, 1996